A Comparative study of transmembrane diffusion and permeation of ibuprofen across synthetic membranes using franz diffusion cells

Pharmaceutics

Volumn 2, Issue 2, 2010, Pages 209-223

  Ng, Shiow Fern ^a   Rouse, Jennifer ^b   Sanderson, Dominic ^c   Eccleston, Gillian ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Franz diffusion cells; Ibuprofen drug diffusion; In vitro absorption; Synthetic membranes; Transdermal absorption

Indexed keywords

IBUPROFEN;

ARTICLE; CELL MEMBRANE TRANSPORT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DIFFUSION; DRUG FORMULATION; DRUG QUALITY; DRUG SOLUBILITY; DRUG TRANSPORT; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; MEMBRANE MODEL; PARTICLE SIZE; POROSITY; PRODUCT DEVELOPMENT; THICKNESS;

EID: 78650256116     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics2020209     Document Type: Article

References (35)

1. Franz, T.J. Percutaneous absorption. On the relevance of In vitro data. J. Invest. Dermatol. 1975, 64, 190-195.
2. Franz, T.J. The finite dose technique as a valid in vitro model for the study of percutaneous absorption. Curr. Probl. Dermatol. 1978, 7, 58-68.
3. Zorin, S.; Kuylenstierna, F.; Thulin, H. In vitro test of Nicotine's permeability through human skin. Risk evaluation and safety aspects. Am. Occup. Hyg. 1999, 43, 405-413.
4. Siewert, M.; Dressman, J.; Brown, C.K.; Shah, V.P. FIP/AAPS guidelines to dissolution/In vitro release testing of novel/special dosage forms. AAPS PharmSci. Tech. 2003, 4, Article 7.
5. Shah, V.; Elkins, J.; Williams, R. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharm. Dev. Technol. 1999, 4, 377-385.
6. Ueda, C.T.; Shah, V.P.; Derdzinski, K.; Ewing, G.; Flynn, G.; Maibach, H.; Marques, M.; Rytting, H.; Shaw, S.; Thakker, K.; Yacobi, A. Topical and Transdermal Drug Products. Pharmacopeial Forum. 2009, 35, 750-764.
7. Twist, J.; Zatz, J. Membrane - solvent - solute interaction in a model permeation system. J. Pharm. Sci. 1988, 77, 538-540.
8. Twist, J.N.; Zatz, J.L. Influence of solvents on paraben permeation through idealized skin model membranes. J. Soc. Cosmet. Chem. 1986, 37, 429-444.
9. Corbo, M.; Schultz, T.W.; Wong, G.K.; van Buskirk, G.A. Development and validation of in vitro release testing methods for semisolid formulations. Pharm. Tech. 1993, 9, 112-128.
10. Pellett, M.A.; Castellano, S.; Hadgraft, J.; Davis, A.F. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J. Control. Release 1997, 46, 205-214.
11. Addicks, W.J.; Flynn, G.L.; Weiner, N. Validation of a flow-through diffusion cell for use in transdermal research. Pharm. Res. 1987, 4, 337-341.
12. Bonferoni, M.C.; Rossi, S.; Ferrari, F.; Caramella, C. A modified Franz diffusion cell for simultaneous assessment of drug release and washability of mucoadhesive gels. Pharm. Dev. Tech. 1999, 4, 45-53.
13. Chattaraj, S.; Kanfer, I. 'The insertion cell': a novel approach to monitor drug release from semi- solid dosage forms. Int. J. Pharm. 1996, 133, 59-63.
14. Chattaraj, S.C.; Kanfer, I. Release of acyclovir from semisolid dosage forms: a semi-automated procedure using a simple plexiglass flow-through cell. Int. J. Pharm. 1995, 125, 215-222.
15. Clement, P.; Laugel, C.; Marty, J.-P. Influence of three synthetic membranes on the release of caffeine from concentrated w/o emulsions. J. Controlled Release 2000, 66, 243-254.
16. Dias, M.; Raghavan, S.L.; Hadgraft, J. ATR-FTIR spectroscopic investigation on the effect of solvents on the permeation of benzoic acid and salicylic acid through silicone membranes. Int. J. Pharm. 2001, 216, 51-59.
17. Friend, D.; Catz, P.; Heller, J.; Okagaki, M. Transdermal delivery of Levonorgestrel IV: Evaluation of membranes. J. Pharm. Sci. 1989, 78, 477-481.
18. Liaw, J.; Lin, Y.-C. Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gel as a release vehicle for percutaneous fentanyl. J. Control. Release 2000, 68, 273-282.
19. Morell, J.L.P.; Claramonte, M.D.C.; Vialard, A.P. Validation of a release diffusion cell for topical dosage forms. Int. J. Pharm. 1996, 137, 49-55.
20. Proniuk, S.; Dixon, S.E.; Blanchard, J. Investigation of the utility of an in vitro release test for optimizing semisolid dosage forms. Pharm. Dev. Technol. 2001, 6, 469-476.
21. Santoyo, S.; Arrelano, A.; Ygartua, P.; Martin, C. In vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skin. Pharm. Acta. Helv. 1996, 71, 141-146.
22. Schwarb, F.P.; Imanidis, G.; Smith, E.W.; Haigh, J.M.; Surber, C. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharm. Res. 1999, 16, 909-915.
23. Shah, V.; Elkins, J.; Hanus, J.; Noorizadeh, C.; Skelly, J. In vitro release of Hydrocortisone from topical preparations and automated procedure. Pharm. Res. 1991, 8, 55-59.
24. Shah, V.; Elkins, J.; Williams, R. In vitro drug release measurement for topical glucocorticoid creams. Pharmacopeial Forum 1993, 19, 5048-5060.
25. Smith, E.W.; Haigh, J.M. In vitro diffusion cell design and validation II. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation. Acta. Pharm. Nord. 1992, 4, 171-178.
26. Thakker, K.D.; Chern, H. Development and validation of in vitro release tests for semisolid dosage forms - case study. Disso. Tech. 2003, 10, 10-15.
27. Welin-Berger, K.; Neelissen, J.A.M.; Bergenstahl, B. The effect of rheological behaviour of a topical anaesthetic formulations on the release and permeation rates of the active compound. Eur.J. Pharm. Sci. 2001, 13, 309-318.
28. FDA-SUPAC-SS. Guidance for Industry. SUPAC-SS Non-sterile Semisolid Dosage Forms. Scale-up and Postapproval Changes: Chemistry, Manufacturing and Controls. In vitro Release Testing and In Vivo Bioequivalence Documentation 1997; pp. 19-24.
29. Shah, V.P.; Elkins, J.S.; Lam, S.Y.; Skelly, J.P. Determination of in vitro drug release from hydrocortisone creams. Int. J. Pharm. 1989, 53, 53-39.
30. Wu, S.T.; Shiu, G.K.; Simmons, J.E.; Bronaugh, R.L.; Skelly, J.P. In vitro release of nitroglycerin from topical products by use of artificial membranes. J. Pharm. Sci. 1992, 81, 1153-1156.
31. Gallagher, S.J.; Trottet, L.; Carter, T.P.; Heard, C.M. Effects of membrane type and liquid/liquid phase boundary on in vitro release of Ketoprofen from gel formulations. J. Drug target. 2003, 11, 373-379.
32. Hatanaka, T.; Inuma, M.; Morimoto, Y. Prediction of skin permeability of drugs. 1. Comparison with artificial membrane. Chem. Pharm. Bull. 1990, 38, 3452-3459.
33. Chenoweth, D.E.; Cheung, A.K.; Henderson, L.W. Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int. 1983, 24, 764-769.
34. Bellomo, R.; Ronco, C. An Introduction to continuous renal replacement therapy. In Atlas of Hemodialysis; Bellomo, R., Baldwin, I., Ronco, C., Thomas, G., Eds.; Bailliere Tindall: London, UK, 2001; Volume 1, pp. 1-10.
35. Cronin, M.T.D.; Dearden, J.C.; Moss, G.P.; Murray-Dickson, G. Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationship. Eur. J. Pharm. Sci. 1998, 7, 325-330.